E-ISSN 1309-4866
Research Article
Validity and Reliability of the Turkish Version of the 8-Item Parkinson’s Disease Questionnaire
1 Dokuz Eylül University School of Physical Therapy and Rehabilitation, İzmir, Turkey  
2 Department of Physiotherapy and Rehabilitation, Gazi University School of Health Sciences, Ankara, Turkey  
3 Department of Neurology, Dokuz Eylül University School of Medicine İzmir, Turkey  
4 Division of Basic Medical Sciences, Department of Biostatistics and Medical Informatics, Dokuz Eylül University School of Medicine, İzmir, Turkey  
Arch Neuropsychiatry ; : -
DOI: 10.5152/npa.2017.19343
This article was viewed 68 times, downloaded 0 times

Key Words: Parkinson’s disease, quality of life, PDQ-8, reliability, validity, Turkey
Abstract

Introduction: Symptomatic control and improvement of health-related quality of life (HRQoL) is a key feature of the management of patients with Parkinson’s disease (PD). The 39-item Parkinson’s Disease Questionnaire (PDQ) and its short version, PDQ-8, validated disease-specific patient-reported instruments, have been highly recommended to use for assessing HRQoL in patients with PD. The aim of this study was to assess the reliability and validity of the Turkish version of the PDQ-8.

 

Methods: Eighty-three patients with PD were recruited for this methodological and cross-sectional study. The PDQ-8 was repeated to assess the test-retest reliability after one-week interval. The participants completed the 36-Item Short Form Health Survey (SF-36) as a generic HRQoL previously validated in Turkey. The Hoehn & Yahr stages of the patients were also determined. The SF-36 and Hoehn & Yahr stages were used to assess the convergent validity of the PDQ-8.

 

Results: The Cronbach’s alpha coefficient was 0.78 (95% CI:  0.70–0.84, p<0.001) for PDQ-8. The test-retest reliability was very high as the intra-class correlation coefficient was 0.97 (95% CI:  0.93–0.99, p<0.001). The PDQ-8 had significant correlations with the physical and mental component scores of SF-36 (ρ=–0.52, p<0.001 and ρ=–0.64, p<0.001, respectively) and Hoehn & Yahr stages (ρ=0.56, p<0.001). There was no evidence of floor or ceiling effects.

 

 

Conclusion: The results of this study suggest that the Turkish version of the PDQ-8 is a reliable, valid, less time-consuming, and brief disease-specific instrument to assess HRQoL in patients with Parkinson’s disease.

Key Words
Authors
All
Author's Corner
Announcements
Survey
AVES | Copyright © 2017 Turkish Neuropsychiatric Society | Latest Update: 03.10.2017